CERCARE Stroke

Cercare Medical

CERCARE Stroke provides AI-driven stroke lesion identification and quantification together with both traditional blood flow (CBF), blood volume (CBV), mean transit time (MTT), and delay images and perfusion maps of oxygen extraction and metabolism for stroke assessment. The solution works in both CT and MRI settings and can be integrated into clinical workflows in various ways.

Product specifications

Information source: Vendor
Last updated: Sept. 22, 2021

General
Product name	CERCARE Stroke
Company	Cercare Medical
Subspeciality	Neuro
Modality	CT, MR
Disease targeted	Stroke
Key-features	stroke lesions identification, stroke lesions quantification, parametric maps
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps)
Data characteristics
Population	All with suspicion of stroke
Input	MR PWI, MR DWI, MR T2Flair, CTP
Input format	DICOM
Output	segmentation overlay, heatmap overlay
Output format	DICOM
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
Certification
CE	Certified, Class IIa , MDD
FDA	No or not yet
Market presence
On market since	11-2019
Distribution channels	syngo.via OpenApps, Sectra Amplifier Store, Blackford, Wellbeing Software
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers